Antiangiogenic Therapy in Hematologic Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|11|1221-1234

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.11, 2004-04, pp. : 1221-1234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

By Bose Prithviraj   Simmons Gary L   Grant Steven  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 723-738

Informa Healthcare

Access to resources Recommend Favorite

Approaches to Optimize Gene Therapy for the Treatment of Hematologic Malignancies: Overcoming the Obstacles

By  

Current Gene Therapy, Vol. 16, Iss. 6, 2017-03 ,pp. : 390-400

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotoxins in the Treatment of Hematologic Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 10, 2006-01 ,pp. : 1301-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Ras as a therapeutic target in hematologic malignancies

By Alvarado Yesid   Giles Francis J  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 271-284

Informa Healthcare

Access to resources Recommend Favorite

Invasive Aspergillosis in Children with Hematologic Malignancies

By Hasan Rashed A.   Abuhammour Walid  

Pediatric Drugs, Vol. 8, Iss. 1, 2006-01 ,pp. : 15-24

Adis International

Access to resources Recommend Favorite